Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Latest filing published 17 Sept 2026 for Travere Therapeutics, Inc., €60k. Read the official filing
Filing timeline
BuySaleSandra Calvin
Insider track record
Disclosed buys
0
Disclosed sells
13
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Sandra Calvin: trading record in brief
Sandra Calvin is a declared insider of Travere Therapeutics, Inc. (senior executive), with filings sourced from SEC (Form 4). Between 24 January 2022 and 15 September 2026, the trades on record add up to 28 filings.
The open-market record consists of 13 sales worth €1.5M, with no purchase. The rest of the record consists of 5 share grants and 10 option exercises. So far in 2026, the count stands at no purchases and 4 sales.
Most recently, on 17 September 2026, the filings show an option exercise worth €29k in Travere Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Sandra Calvin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
2,500 shares@ US$27.500.0011% mcap2.3% of flowCommon StockSEC:0001882909-26-000004:0
1,250 shares@ US$22.400.0004% mcap1.0% of flowCommon StockSEC:0001882909-26-000004:1
1,625 shares@ US$20.460.0005% mcap1.1% of flowCommon StockSEC:0001882909-26-000004:2
4,275 shares@ US$62.1350.0042% mcap9.0% of flowCommon StockSEC:0001882909-26-000004:3
800 shares@ US$62.84810.0008% mcap1.7% of flowCommon StockSEC:0001882909-26-000004:4
300 shares@ US$63.66330.0003% mcap0.7% of flowCommon StockSEC:0001882909-26-000004:5
2,500 shares@ US$22.400.0010% mcap3.0% of flowCommon StockSEC:0001882909-26-000003:0
6,250 shares@ US$8.930.0010% mcap3.0% of flowCommon StockSEC:0001882909-26-000003:1
6,500 shares@ US$20.460.0024% mcap7.0% of flowCommon StockSEC:0001882909-26-000003:2
21,977 shares@ US$41.070.016% mcap47.7% of flowCommon StockSEC:0001882909-26-000003:3
15,180 shares0Common StockSEC:0001882909-26-000001:0
7,402 shares@ US$40.0011.7% of flowCommon StockSEC:0001882909-25-000008:0
2,910 shares@ US$36.004.7% of flowCommon StockSEC:0001882909-25-000006:0
10,000 shares@ US$25.2512.2% of flowCommon StockSEC:0001882909-25-000004:0
10,000 shares@ US$16.2325.0% of flowCommon StockSEC:0001415889-25-003822:0
13,000 shares0Common StockSEC:0001415889-25-003061:0
925 shares@ US$18.94082.7% of flowCommon StockSEC:0001415889-25-001997:0
15,000 shares@ US$12.6729.0% of flowCommon StockSEC:0001415889-24-030210:0
15,000 shares@ US$12.6728.8% of flowCommon StockSEC:0001415889-24-027672:0
12,500 shares0Common StockSEC:0001415889-24-002279:0
910 shares@ US$9.06841.2% of flowCommon StockSEC:0001415889-24-001796:0
436 shares@ US$16.591.0% of flowCommon StockSEC:0001209191-23-028993:0
10,000 shares0Common StockSEC:0001209191-23-006413:0
905 shares@ US$21.90442.9% of flowCommon StockSEC:0001209191-23-005037:0
349 shares@ US$28.001.6% of flowCommon StockSEC:0001209191-22-050038:0
25 of 28 declarations
